Verrica Pharmaceuticals Inc.

Healthcare · Biotechnology · United States

Last price 3.35 USD (Oct 30, 2026, 2:27 PM EDT) · Market cap 57.55M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of...